TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
INDP
Indaptus Therapeutics
$
()
INDP
Indaptus Therapeutics announces interim data from Phase 1 INDP-D101 trial
INDP
11/6/2023 - 08:13am
Indaptus to present interim data of first cohort in trial of INDP-D101
INDP
10/31/2023 - 09:12am
Indaptus Therapeutics doses first patient in second cohort of study of Decoy20
INDP
9/19/2023 - 08:03am
Indaptus Therapeutics reports Q2 EPS (39c) vs (46c) last year
INDP
8/14/2023 - 08:02am
Indaptus Therapeutics announces opening of next cohort in trial of Decoy20
INDP
8/10/2023 - 08:46am
Indaptus Therapeutics appoints Waltzman as Chief Medical Officer
INDP
,
MTEM
8/7/2023 - 08:09am
Indaptus Therapeutics expects cash to fund operations into 2Q24
INDP
5/11/2023 - 07:06am
Indaptus Therapeutics reports Q1 EPS (51c) vs. (41c) last year
INDP
5/11/2023 - 07:05am
Indaptus receives notice of allowance from IP India for Decoy platform
INDP
5/9/2023 - 08:25am
Indaptus Therapeutics presents data on preclinical efficacy of Decoy
INDP
4/19/2023 - 08:10am
Indaptus Therapeutics receives Brazilian patent allowance for Decoy platform
INDP
4/17/2023 - 08:15am
Indaptus Therapeutics price target lowered to $12 from $15 at H.C. Wainwright
INDP
3/20/2023 - 06:16am
Indaptus Therapeutics reports 2022 EPS ($1.73) vs ($1.89) last year
INDP
3/17/2023 - 08:07am
Indaptus Therapeutics activates Emory Winship Cancer Institute as trial site
INDP
3/13/2023 - 08:41am
Indaptus Therapeutics doses first subject in ongoing Phase 1 lab
INDP
3/7/2023 - 08:27am
dynamic_feed
Breaking News
search
Search
menu
Menu